1.
Schavgoulidze A, Lauwers-Cances V, Perrot A, Cazaubiel T, Chretien M-L, Moreau P, Facon T, Leleu X, Karlin L, Stoppa A-M, Decaux O, Belhadj K, Arnulf B, Mohty M, ariette CM, Fohrer-Sonntag C, Lenain P, Marolleau J-P, Tiab M, Araujo C, Orsini-Piocelle F, Jaccard A, Roussel M, Benboubker L, Eveillard J-R, Dib M, Divoux M, Attal M, Avet-Loiseau H, Corre J. Heterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma. haematol [Internet]. 2022Sep.29 [cited 2024Mar.3];108(5):1374-8. Available from: https://haematologica.org/article/view/haematol.2021.280566